vimarsana.com

Page 49 - ஒன்றுபட்டது நாடுகள் நிலையான வளர்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SMIC joins 50 Sustainability and Climate Change leaders campaign

Published April 20, 2021, 5:30 AM SM Investments Corporation (SMIC) has joined a business group of dedicated global sustainability champions through the 50 Sustainability & Climate Leaders campaign with a focus on responding to climate change. This makes SMIC the only Filipino company to join the campaign among countries like the USA, Germany, Italy, United Kingdom, Kenya, Switzerland and the Netherlands. The 50 Sustainability & Climate Leaders platform serves as a response from international businesses to demonstrate their desire, leadership and commitment to take effective action in the fight against climate change.  The 50 Climate Leaders series led by the TBD Media Group is a multi-media campaign that will showcase effective leadership in: energy transition; climate finance and carbon pricing; industry transition; nature-based solutions; cities and local action; and resilience.

University of Helsinki sold cancer and infectious disease vaccination platform called PeptiBAC to Valo Therapeutics

Potential for regional tuberculosis vaccines, novel personalized cancer vaccines, and improving checkpoint inhibition therapy University of Helsinki and a spinout-company from the University of Helsinki, Valo Therapeutics Limited (Valo Tx) , announced today that Valo Tx acquires the intellectual property rights for the proprietary ´PeptiBAC´technology from the University of Helsinki, Finland. Valo Tx is the developer of novel, adaptable immunotherapy platforms for cancer and infectious diseases. University of Helsinki owns 21% of Valo Tx. PeptiBAC uses the BCG (Bacillus Calmette-Guèrin) vaccine as a backbone for delivery of disease specific peptides. The technology has preventative potential in infectious diseases, specifically tuberculosis (TB, caused by Mycobacterium tuberculosis (MTB)), as well therapeutic potential in cancer. The BGC vaccine, one of the earliest immunotherapies, has been widely used globally for decades. It is safe and well tolerated, with over 10

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.